Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

MEBO - UBIOME study 2018

NCT03582826
ClinicalTrials.gov
MEBO Gut Microbiome Study
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER : 10% OFF
Join/Watch the weekly
TMAU UP Podcasts

Videos : TMAU stories

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Friday, August 29, 2008

Xenobiotic metabolism enzymes : an attempt at an explanation

This is an attempt to explain what are often refered to as the 'xenobiotic enzymes' or 'drug metabolizing enzymes' (amongst other hard to define names) . These are the cell enzymes that often mostly deal with 'external' chemicals that get into the bloodstream (especially drugs). Usually they are most abundant in the liver (hepatic enzymes) but they can be present anywhere.

They are often classed as phase1/phase2 (biotransformation) enzymes.

Phase1 is the oxidizing layer (the 'non-synthetic reaction' enzymes) (they also do other things, such as reduction)
the main family of phase1 (the heavy duty ones) are the CYP450 family. The FMO family are another phase1 enzyme.

The phase2 enzymes are the 'conjugation reaction enzymes'. They add something to the chemical to completely neutralize it. for instance a sulfur molecule. The main phase2 enzyme reactions are glucuronidation, sulfation, methylation and glutathione, acetylation, and amino acid conjugation. Both phases aren't always needed to detoxify something. For instance trimethylamine only needs to be oxidized by FMO3.

Most of these enzymes DNA can be increasingly switched on or off by chemicals. This is known as induction or inhibition. For instance a compound in grapefruit juice can inhibit many of the CYP450 enzymes. FMO is probably still taught as being uninducible/uninhibitable, but a study has shown a compound in cruciferous vegetables can inhibit FMO.

Everyones 'maximum' amount of of each enzyme varies in general. Since these enzymes often activate or detoxify drugs, they can often explain why someone reacts badly to certain medicines. Researchers are trying to understand these reactions through the science of pharmacogenetics

These enzymes also alter a lot of other chemicals in the body. for instance, detoxifying/activating hormones, neurotransmitters etc ('endogenous substrates').

keywords:
induction
substrate
inhibition
CYP450
phase1/phase2
drug metabolizing enzymes
endogenous/exogonous


0 comments:

Post a Comment